Bizily Scott — SEC insider filings

SEC reporting owner CIK 1920738. 37 insider filings on record with FilingPulse; latest filed 2026-10-20.

Transaction summary — filings shown

Covers all 37 filings on record, filed 2022-06-21 to 2026-10-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
4D Molecular Therapeutics, Inc. (FDMT)Chief Legal Officer37—43 legs · 93,776 sh · $1,932,85996

Insider filings — Bizily Scott

FiledFormIssuerReported transactionsSource
2026-10-2044D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 1,635 @ $4.14 · Sale (S): 1,635 @ $12.84 · Option exercise (M): 1,635 (derivative) @ $0EDGAR
2026-09-2244D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 1,635 @ $4.14 · Sale (S): 1,635 @ $13.65 · Option exercise (M): 1,635 (derivative) @ $0EDGAR
2026-09-0344D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 584 @ $6.49 · Sale (S): 584 @ $14 · Option exercise (M): 584 (derivative) @ $0EDGAR
2026-08-1744D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 1,635 @ $4.14 · Sale (S): 1,635 @ $12 · Option exercise (M): 1,635 @ $4.14 · Sale (S): 1,635 @ $12.20 · Option exercise (M): 1,635 (derivative) @ $0 · Option exercise (M): 1,635 (derivative) @ $0EDGAR
2026-07-0244D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 814 @ $4.14 · Option exercise (M): 5,752 @ $6.49 · Sale (S): 6,566 @ $14 · Option exercise (M): 814 (derivative) @ $0 · Option exercise (M): 5,752 (derivative) @ $0EDGAR
2026-06-2544D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 9,810 @ $4.14 · Sale (S): 9,810 @ $12 · Option exercise (M): 9,810 (derivative) @ $0EDGAR
2026-03-2744D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 217,000 (derivative) @ $0EDGAR
2025-12-1944D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 1,635 @ $4.14 · Sale (S): 1,635 @ $10.90 · Option exercise (M): 1,635 (derivative) @ $0EDGAR
2025-11-1944D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 1,635 @ $4.14 · Sale (S): 1,635 @ $10.59 · Option exercise (M): 1,635 (derivative) @ $0EDGAR
2025-10-2744D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 1,084 @ $6.49 · Sale (S): 2,678 @ $12 · Option exercise (M): 1,084 (derivative) @ $0EDGAR
2025-10-2044D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 1,635 @ $4.14 · Sale (S): 1,635 @ $10.17 · Option exercise (M): 1,635 (derivative) @ $0EDGAR
2025-10-1444D Molecular Therapeutics, Inc. (FDMT)Sale (S): 2,408 @ $10EDGAR
2025-09-2644D Molecular Therapeutics, Inc. (FDMT)Sale (S): 2,407 @ $8EDGAR
2025-03-1044D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 78,500 (derivative) @ $0EDGAR
2024-09-1844D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 500 @ $6.49 · Sale (S): 500 @ $16.33 · Option exercise (M): 500 (derivative) @ $0EDGAR
2024-08-2144D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 500 @ $6.49 · Sale (S): 500 @ $15 · Option exercise (M): 500 (derivative) @ $0EDGAR
2024-07-1844D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 500 @ $6.49 · Option exercise (M): 1,250 @ $8.04 · Sale (S): 1,750 @ $27.11 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2024-07-1544D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 1,996 @ $15.78 · Sale (S): 1,996 @ $25 · Option exercise (M): 1,996 (derivative) @ $0EDGAR
2024-07-0344D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 1,332 @ $6.49 · Option exercise (M): 2,916 @ $8.04 · Sale (S): 4,248 @ $21.36 · Option exercise (M): 1,332 (derivative) @ $0 · Option exercise (M): 2,916 (derivative) @ $0EDGAR
2024-06-2044D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 500 @ $6.49 · Option exercise (M): 1,250 @ $8.04 · Sale (S): 1,750 @ $23.71 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2024-05-2044D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 500 @ $6.49 · Option exercise (M): 1,250 @ $8.04 · Sale (S): 1,283 @ $25.34 · Sale (S): 467 @ $25.75 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2024-04-1844D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 500 @ $6.49 · Option exercise (M): 1,250 @ $8.04 · Sale (S): 1,750 @ $25.74 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2024-04-0344D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 1,332 @ $6.49 · Option exercise (M): 2,916 @ $8.04 · Option exercise (M): 1,996 @ $15.78 · Option exercise (M): 1,909 @ $20.24 · Sale (S): 8,153 @ $31.78 · Option exercise (M): 1,332 (derivative) @ $0 · +3 moreEDGAR
2024-03-2944D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 4,342 @ $25.98 · Option exercise (M): 1,491 @ $25.98 · Sale (S): 5,833 @ $35.04 · Option exercise (M): 4,342 (derivative) @ $0 · Option exercise (M): 1,491 (derivative) @ $0EDGAR
2024-03-2044D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 500 @ $6.49 · Option exercise (M): 1,250 @ $8.04 · Sale (S): 1,750 @ $31.27 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2024-02-2944D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 1,909 @ $20.24 · Sale (S): 1,909 @ $30 · Option exercise (M): 1,909 (derivative) @ $0EDGAR
2024-02-2144D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 500 @ $6.49 · Option exercise (M): 1,250 @ $8.04 · Sale (S): 1,750 @ $27.67 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2024-02-1244D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 1,332 @ $6.49 · Sale (S): 1,332 @ $27.50 · Option exercise (M): 2,916 @ $8.04 · Sale (S): 2,916 @ $27.50 · Option exercise (M): 1,996 @ $15.78 · Sale (S): 1,996 @ $27.50 · +3 moreEDGAR
2023-12-1344D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 130,000 (derivative) @ $0EDGAR
2023-06-1244D Molecular Therapeutics, Inc. (FMDT)Option exercise (M): 3,750 @ $8.04 · Sale (S): 3,750 @ $20.85 · Option exercise (M): 3,750 (derivative) @ $0EDGAR
2023-06-0644D Molecular Therapeutics, Inc. (FMDT)Option exercise (M): 1,875 @ $6.49 · Sale (S): 2,247 @ $18.31 · Option exercise (M): 1,875 (derivative) @ $0EDGAR
2023-04-2544D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 3,750 @ $8.04 · Sale (S): 3,750 @ $20 · Option exercise (M): 3,750 (derivative) @ $0EDGAR
2023-03-0344D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 1,875 @ $6.49 · Sale (S): 2,248 @ $19.30 · Option exercise (M): 1,875 (derivative) @ $0EDGAR
2023-02-1444D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2022-12-0544D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 1,875 @ $6.49 · Sale (S): 400 @ $21.52 · Sale (S): 975 @ $22.71 · Sale (S): 400 @ $23.25 · Sale (S): 100 @ $24.49 · Option exercise (M): 3,750 @ $8.04 · +7 moreEDGAR
2022-09-0644D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2022-06-2144D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 24,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-03-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1920738 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs